Tissue engineering in the cardiovascular system: progress toward a tissue engineered heart
- PMID: 11500813
- DOI: 10.1002/ar.1116
Tissue engineering in the cardiovascular system: progress toward a tissue engineered heart
Abstract
Achieving the lofty goal of developing a tissue engineered heart will likely rely on progress in engineering the various components: blood vessels, heart valves, and cardiac muscle. Advances in tissue engineered vascular grafts have shown the most progress to date. Research in tissue-engineered vascular grafts has focused on improving scaffold design, including mechanical properties and bioactivity; genetically engineering cells to improve graft performance; and optimizing tissue formation through in vitro mechanical conditioning. Some of these same approaches have been used in developing tissue engineering heart valves and cardiac muscle as well. Continued advances in scaffold technology and a greater understanding of vascular cell biology along with collaboration among engineers, scientists, and physicians will lead to further progress in the field of cardiovascular tissue engineering and ultimately the development of a tissue-engineered heart.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
Cardiovascular tissue engineering.Cardiovasc Pathol. 2002 Nov-Dec;11(6):305-17. doi: 10.1016/s1054-8807(02)00130-8. Cardiovasc Pathol. 2002. PMID: 12459430 Review. No abstract available.
-
[Progress in studies of tissue-engineered heart valves].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2002 Jan;19(1):132-4. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2002. PMID: 11951501 Review. Chinese.
-
Tissue engineering: current state and perspectives.Appl Microbiol Biotechnol. 2004 Jul;65(1):1-8. doi: 10.1007/s00253-004-1580-z. Epub 2004 Feb 20. Appl Microbiol Biotechnol. 2004. PMID: 15221227 Review.
-
Myocardial restoration and tissue engineering of heart structures.Methods Mol Med. 2007;140:273-90. doi: 10.1007/978-1-59745-443-8_15. Methods Mol Med. 2007. PMID: 18085214
-
Environmental regulation of valvulogenesis: implications for tissue engineering.Eur J Cardiothorac Surg. 2011 Jan;39(1):8-17. doi: 10.1016/j.ejcts.2010.05.032. Epub 2010 Jul 15. Eur J Cardiothorac Surg. 2011. PMID: 20637649 Review.
Cited by
-
Manipulating the microvasculature and its microenvironment.Crit Rev Biomed Eng. 2013;41(2):91-123. doi: 10.1615/critrevbiomedeng.2013008077. Crit Rev Biomed Eng. 2013. PMID: 24580565 Free PMC article. Review.
-
Growth and electrophysiological properties of rat embryonic cardiomyocytes on hydroxyl- and carboxyl-modified surfaces.J Biomater Sci Polym Ed. 2008;19(10):1319-31. doi: 10.1163/156856208786052399. J Biomater Sci Polym Ed. 2008. PMID: 18854125 Free PMC article.
-
Autologous bone grafts with MSCs or FGF-2 accelerate bone union in large bone defects.J Orthop Surg Res. 2016 Sep 26;11(1):105. doi: 10.1186/s13018-016-0442-6. J Orthop Surg Res. 2016. PMID: 27669690 Free PMC article.
-
Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells.Circulation. 2005 Feb 1;111(4):442-50. doi: 10.1161/01.CIR.0000153847.47301.80. Circulation. 2005. PMID: 15687132 Free PMC article.
-
Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration.Circulation. 2004 Aug 24;110(8):962-8. doi: 10.1161/01.CIR.0000140667.37070.07. Epub 2004 Aug 9. Circulation. 2004. PMID: 15302801 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical